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Regeneration of injured nerves is likely occurring in the peripheral nervous system, but 
not in the central nervous system. Although protein-coding gene expression has been 
assessed during nerve regeneration, little is currently known about the role of non-coding 
RNAs (ncRNAs). This leaves open questions about the potential effects of ncRNAs at 
transcriptome level. Due to the limited availability of human neuropathic pain (NP) data, 
we have identified the most comprehensive time-course gene expression profile referred 
to sciatic nerve (SN) injury and studied in a rat model using two neuronal tissues, namely 
dorsal root ganglion (DRG) and SN. We have developed a methodology to identify dif-
ferentially expressed bioentities starting from microarray probes and repurposing them 
to annotate ncRNAs, while analyzing the expression profiles of protein-coding genes. 
The approach is designed to reuse microarray data and perform first profiling and then 
meta-analysis through three main steps. First, we used contextual analysis to identify 
what we considered putative or potential protein-coding targets for selected ncRNAs. 
Relevance was therefore assigned to differential expression of neighbor protein-coding 
genes, with neighborhood defined by a fixed genomic distance from long or antisense 
ncRNA loci, and of parental genes associated with pseudogenes. Second, connectivity 
among putative targets was used to build networks, in turn useful to conduct inference 
at interactomic scale. Last, network paths were annotated to assess relevance to NP. We 
found significant differential expression in long-intergenic ncRNAs (32 lincRNAs in SN and 
8 in DRG), antisense RNA (31 asRNA in SN and 12 in DRG), and pseudogenes (456 in 
SN and 56 in DRG). In particular, contextual analysis centered on pseudogenes revealed 
some targets with known association to neurodegeneration and/or neurogenesis pro-
cesses. While modules of the olfactory receptors were clearly identified in protein–protein 
interaction networks, other connectivity paths were identified between proteins already 
investigated in studies on disorders, such as Parkinson, Down syndrome, Huntington 
disease, and Alzheimer. Our findings suggest the importance of reusing gene expression 
data by meta-analysis approaches.
Keywords: neuropathic pain, microarray data reuse, differential expression, time-course profiling, pathway 
analysis, non-coding rnas, networks
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inTrODUcTiOn
Neuropathic pain (NP) is caused by intense damage brought to 
nervous system and has a differentiated origin (1). The cause 
could be either injury affecting the somatosensory nervous 
system or the damages to either the peripheral nervous system 
or the central nervous system (CNS) (2). NP is categorized into 
peripheral and central. The central NP is found implicated in 
spinal cord injury and in a few stroke cases. For instance, a 
significant presence of NP was detected in patients with spi-
nal cord injury that experienced chronic pain (3). Peripheral 
nerve injuries cause damage to both the nerve and the adjacent 
connective tissue, but the injured nerves can regenerate in the 
peripheral nervous system by the activation of the intrinsic 
growth capacity of neurons (4). However, injured nerves 
generally fail to regenerate in the CNS (5). Various studies on 
sciatic nerve (SN) injury have been reported with reference to 
the rat model (6, 7), which is considered as the reference in 
our work too. Consisting of mixed populations of motor and 
sensory axons, SN is commonly addressed in nerve regenera-
tion studies. The sensory neurons extending into SN are located 
in the L4–L6, lumbar vertebrae fourth through sixth dorsal root 
ganglion (DRG).
Due to the relevance of measuring the expression levels of 
both DRG and SN tissues, an opportunity is currently offered by 
many available microarray data, through which cross-reference 
studies and comparative evaluations can be performed. Meta-
analyses have been conducted in many independent experi-
ments to detect genes regulated by chronic pain states (8). With 
a focus limited to mRNA transcripts, little or no relevance 
was assigned to non-coding RNAs (ncRNAs) (9). A couple 
of exceptions were due to microRNA profiling based on SN, 
and to lncRNAs with temporal profile monitored after DRG 
injury, respectively (6, 9). This knowledge gap has motivated 
our work. An opportunity was offered by the reuse of data 
from open access resources, with the aim of overcoming the 
paucity of evidences due to limited experiments, high costs, 
and technical difficulties.
Peripheral inflammation and nerve injury cause changes in the 
expression of some miRNAs (7, 9, 10). Other ncRNAs might be 
considered relevant too, as they may regulate genomic expression 
to an extent yet largely unknown (11). Most studies have been 
based on deep sequencing and associated bioinformatic analyses 
lacking clear reference to functions, but reporting on target genes. 
Naturally enough, knockout studies may advance knowledge, 
but human transcripts are problematic to examine in vivo (12). 
Despite problems with cis-specific functions, mechanisms 
explaining regulatory functions have been shown especially with 
reference to epigenetic modulation, protein scaffolding, miRNA 
sequestration, competitive inhibition, etc. These processes include 
the ability to modulate target gene transcription (13).
The functional significance of such regulators has been 
discussed in physiology, development, and also various disease 
processes (14–16). However, up to now, relatively few ncRNAs 
have been studied. For instance, the expression of some antisense 
transcripts is linked to the activity of neighbor genes (17), but 
the regulation of gene expression by antisense transcripts is not 
acting as an isolated but rather as part of integrated mechanisms 
to achieve complex regulatory effects (18). Additional consid-
eration deserves the complexity of lncRNAs in relation with 
the architecture of RNA-binding proteins, due to the presence 
of multiple RNA-binding domains that may recognize distinct 
“targets” (19). There is currently little evidence for direct interac-
tion between lncRNAs and DNA. RNA–DNA hybrids or triplex 
structures can allow single strands of RNA to interact with DNA 
duplexes by base–pair interactions. These direct RNA–DNA 
interactions could efficiently and selectively target RNA signals 
to genomic loci (20).
Antisense biotypes were identified in the mammalian nerv-
ous system, including in chronic pain-related regions (21). This 
holds for the Kcna2 antisense RNA in DRG, for instance, which 
is overexpressed after peripheral nerve injury (22). In NP regula-
tion, the relationships between protein-coding genes and ncRNA 
expression are also important for the critical role that the former 
play, that of target genes. Our study looks at such associations, 
focusing on the analysis of differential expression in both regula-
tors and targets.
We recently reported work with preliminary analysis of the 
dataset GSE30165 (23). The rationale was to identify mRNA 
isoforms and ncRNAs underlying NP, using only the top 250 dif-
ferentially expressed biotypes. In the present work, starting from 
ncRNAs classification and curation in relation to NP, we provided 
further analysis, i.e., contextual annotations for lncRNAs, sug-
gesting a strategy to strengthen inference about the potential 
functional role of ncRNAs. In particular, since overexpression 
of ncRNAs acts toward reduction of the expression of potential 
targets, our evidences suggest to pay attention to putative targets 
potentially associated with regulatory and signaling NP mecha-
nisms, also studied in relation with brain diseases.
MaTerials anD MeThODs
Microarray Data
The raw microarray data were downloaded from the Gene 
Expression Omnibus database1 (GEO), platform Agilent-014879: 
Whole Rat Genome Microarray 4 × 44 K G4131F. Gene expres-
sion signatures for 30 samples were generated, including L4-6 
DRG and proximal SN tissues (0.5  cm) at day 0, day 1, day 4, 
day 7, and day 14 after SN resection. This dataset included three 
samples in each tissue, DRG, and SN, and the expression levels 
were measured for all samples at five time points.
The differential expression was computed with GeneSpring 
(GX V 12.6). The time baseline was assigned the same way in 
both studies, with DRG and SN. Given the start day, 0 day = b, 
further measurements that were taken at successive intervals 
were redefined as: I1 = 1 day − b, I2 = 4 day − b, I3 = 7 day − b, 
I4 = 14 day − b. Sample groups thus appear according to time 
point in each tissue, for a total of five groups. Significance was 
assigned when differences in expression values between the 
groups had fold change (FC) >1.5, and t-test p-values <0.05, then 
adjusted for multiple testing by the false discovery rate (FDR) or 
1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30165 
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Benjamini and Hochberg method (24). The probe sets and genes 
correspondence was established by FDR cutoff q < 0.05, and this 
is a standard way to bypass the problem of probes mapping to 
multiple genes. The outcome of this process (see also Table S8 in 
Supplementary Material) was the gene set called DEGs, retained 
for downstream analysis.
Of course, the stringency of these criteria influences the rela-
tive abundance or paucity of evidences that allow downstream 
analysis and thus inference; however, the goal of capturing 
biotypes other than genes, say ncRNA, suggests considering 
that relatively low expression values should be expected to 
characterize them.
Pathway analysis
Pathway analysis was obtained using the tool GeneGo Metacore™ 
(Thomson Reuters Corporation, New York, NY, USA). The DEGs 
identified by GeneSpring analysis were uploaded to the GeneGo 
website, and core analysis was applied to obtain the list of acti-
vated pathways, using 0.05 as a threshold for p-values. While we 
rely on established tools for protein-coding gene annotations, i.e., 
DEGs enriching for pathway terms, we need to work at a more 
empirical level for the ncRNAs, as explained below.
ncrna annotation
The differentially expressed detections were annotated with both 
protein-coding and non-coding biotypes, as provided by Ensembl 
rel. 77 (25), Rattus_norvegicus.Rnor_6.0.79.gtf, and Mus_mus-
culus.GRCm38.76.gtf. In the non-coding category, annotations 
regarding lncRNAs were provided for pseudogenes, lincRNAs, 
and asRNA – considered of major interest in our work. Due to 
the categories appearing under the label pseudogene, we aimed to 
have one single group, and thus the processed pseudogenes were 
consolidated into the final pseudogene group. Below, we explain 
the annotation strategy for these three major categories. Lastly, 
we indicate the use of targets to build protein–protein interaction 
networks (PINs).
LincRNA Neighbors
The contextual analysis of lincRNAs with respect to the DEG 
targets was established on the basis of the physical proximal 
distance on the chromosome. The mode of action of lncRNAs 
is generally classified into cis and trans regulation [see among 
other references, Ling et al. (26)]. This depends on whether the 
lncRNA regulates neighboring genes, i.e., genes on the same 
chromosomal regions where they are located, or instead distant 
genes, i.e., on other chromosomes. Notably, lncRNAs interact 
directly or indirectly with genomic DNA elements, often 
through proteins that perform specific biological functions, 
and also through other neighbor lncRNAs in a coordinated 
way. Note that lncRNAs may target proteins to exert their 
trans effects, but in such case to know what factors determine 
the RNA–protein interaction requires further study, here not 
pursued.
Locations of DE lincRNAs were obtained from Rattus_nor-
vegicus.Rnor_6.0.79.gtf and Mus_musculus.GRCm38.76.gtf, i.e., 
gene transfer format files downloaded from Ensembl release 77. 
Two text files, one with lincRNA genomic locations (start and 
end positions) and another with protein-coding genomic loca-
tions (start and end positions), allowed lincRNA neighbors to 
be annotated. Genes at both left and right sides of starting and 
ending positions of lincRNAs, and within ±3 Mbps regions, were 
considered as putative targets. Note that this interval is arbitrary, 
and there is not a universally accepted definition of such range. 
In an attempt to explore neighbors of the lncRNA locus that 
confidently allow putative targets to be identified, we assigned 
priority to targets located at the closest possible distance from the 
locus of interest (see Results).
asRNA
They are among the most important categories of lncRNAs and 
known to regulate protein-coding genes on the opposite strand. 
Using information on the genomic coordinates of the genes and 
their coding potential obtained from the GTF files, we looked 
into the specific protein-coding genes that were on the opposite 
strand to DE asRNA in both tissues. Two text files were created 
for rat (i) asRNA file: a text file describing gene_id, chromosome, 
start, end, strand, gene_name obtained from Rattus_norvegicus.
Rnor_6.0.79.gtf and (ii) GTF file: a text file that has all the 
genomic information but not restricted to asRNAs. These two text 
files were parsed through basic Perl scripts and for different steps 
to obtain the asRNA targets. Basically, this involved checking 
whether the chromosome numbers are the same in both asRNA 
and GTF text files and if the strands are opposite, then the order-
ing of the start position of genes in the asRNA file compared to 
the end genomic location, and also of the start position of genes 
in GTF file compared to the end genomic location. Finally, only 
the gene names from the GTF file on the opposite strand to the 
corresponding gene in the asRNA file were retained. Then, the 
same exact protocol was followed to obtain asRNA targets using 
the mouse reference, Mus_musculus.GRCm38.76.gtf.
Pseudogene–Parental Gene Annotations
The differentially expressed pseudogenes obtained for both tis-
sues were annotated with respect to their parental protein-coding 
genes. The pseudogene sequences were mapped against the 
protein-coding gene sequences using BLAST (27), and only the 
unique hits were assigned to parental gene–pseudogene associa-
tions. Fasta sequences for protein-coding genes and pseudogenes 
were downloaded from the rat reference, Rattus_norvegicus.
Rnor_6.0.cdna.all.fa. These two sets of sequences were mapped 
against each other using BLAST and the parameter “-max_tar-
get_seqs:1” to detect only those protein-coding genes that have 
a high-level of sequence homology to the pseudogenes used as 
query. Finally, the output obtained from BLAST was analyzed 
to overcome the multiple associations, i.e., when a pseudogene 
aligns to multiple protein-coding genes. The BLAST output was 
filtered using the “sort –u” option, which sorts the file and 
pipes the output that contains only unique hits. Therefore, only 
unique hits were considered as our final list for the downstream 
analysis. Similar steps were followed to extract parental genes 
from the mouse reference Mus_musculus.GRCm38.cdna.all.fa 
as well, as reported in parenthesis in Table  1. Further control 
of the selected parental genes aimed to identify DE in either 
neuronal tissue.
TaBle 1 | classification of bioentities (source: ensembl) – combined gene annotations for differentially expressed bioentities at different time points 
for the two tissues (sn, Drg).
Biotype sn annotations Drg annotations
interval 1
sn_i1
interval 2
sn_i2
interval 3
sn_i3
interval 4
sn_i4
interval 1
Drg_i1
interval 2
Drg_i2
interval 3
Drg_i3
interval 4
Drg_i4
Protein-coding gene 6392 5722 6436 3788 619 500 1274 2811
Pseudogene 366 (172) 303 (157) 291 (135) 188 (92) 19 (9) 10 (6) 34 (15) 98 (55)
lincRNA 31 (22) 27 (21) 30 (22) 14 (12) 1 1 3 (2) 10 (6)
Antisense 18 (16) 16 (15) 14 (13) 11 (10) 0 0 3 (3) 12 (12)
Numbers in parentheses indicate ncRNAs from mouse reference, compared to rat evidences.
A pathway related to immune response that appears in SN_I1, SN_I3, SN_I4, DRG_I1, DRG_I2, and DRG_I3 involves chemokines, indicating a possible role in neuroinflammation 
and in alteration of neuronal plasticity (28).
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Target-Driven Protein–Protein interaction 
networks
The parental protein genes found differentially expressed in 
either of the neuronal tissues were used to generate the PIN 
using STRING2 (V. 9.1). This is a known state-of-the-art database 
reporting both experimental and predicted protein–protein 
interactions. This network was functional to our downstream 
contextual analysis, i.e., the contextualization of the identified 
targets with respect to biological processes and pathways.
rat Model and Mouse reference
We used Mus_musculus.GRCm38.cdna.all.fa and Rattus_nor-
vegicus.Rnor_6.0.cdna.all.fa from Ensembl (rel 77). The mouse 
was used as a reference only.
resUlTs
Probe and gene annotation
The microarray dataset was profiled for the DEGs in both 
neuronal tissues – DRG and SN – at different time points (see 
Table 1). In addition, annotated differentially expressed probes 
and ncRNAs are uniquely obtained using the mouse reference 
(see Materials and Methods for details and bold numbers in 
parentheses reported in Table 1).
We detected 32 unique lincRNAs in SN and 8 unique 
lincRNAs in DRG. Then, we detected 31 unique antisense in 
SN and 12 unique antisense in DRG. Such antisense detections 
in SN and in DRG were not significantly associated with targets; 
hence, they were no longer explored. We additionally identified 
452 unique pseudogenes in SN and 56 unique pseudogenes 
in DRG, subsequently investigated for their protein-coding 
targets.
Pathways
Pathway analysis was conducted with the tool GeneGo, deliver-
ing evidences displayed in Figures  1A,B and 2A,B and sum-
marized in the top-10 annotated terms for both tissues, DRG 
and SN. The enriching DEG sets appear in supplemental files 
(see Tables S6 and S7 in Supplementary Material for complete 
lists of annotated terms). Also, fractions of genes enriching 
2 http://string-db.org 
pathway terms are reported inside the plots, while the listed 
terms are sorted by FDR-corrected enrichment values (from 
best, at the top).
We can observe among the terms in Figure  1A the one 
annotated as neurophysiological process_Kappa-type opioid 
receptor in transmission of nerve impulses, especially involved 
in DRG_I2. The relevance of this term is associated to CREM 
(activators), AP-1, and P/Q-type calcium channel alpha-1A 
subunit. The latter gene is a voltage-dependent calcium channel 
that mediates the entry of calcium ions into excitable cells and 
is involved in various calcium-dependent processes, like muscle 
contraction, neurotransmitter release, and gene expression. It is 
also primarily expressed in neuronal tissue, and it was shown 
that mutations to this gene could potentially cause two neuro-
logical disorders (29).
We also noted recurrence of cell adhesion_Integrin inside-out 
signaling in T cells at SN_I2, SN_I3, and SN_4, but not at SN_I1. 
This may indicate a possible role for the integrin-regulated cell 
adhesion in tissue morphogenesis and wound healing, together 
with the regulation of cell growth and differentiation, whereas 
the temporal pattern points to recurrence after injury.
Another interesting pathway is immune_response_CCL2_sign-
aling, which is involved mainly in SN and refers to chemokines 
previously shown to be upregulated in injured DRG neurons 
under different NP models (30–33). We found enrichment of 
immune response_NFAT in SN_I2, SN_I4 and signal transduc-
tion_cAMP signaling in DRG_I4 by calcineurin A (catalytic), 
which is a calcium and calmodulin dependent serine/threonine 
protein phosphatase. This gene is relevant for CNS functions, 
such as neurite extension, synaptic plasticity, learning, and 
memory (34, 35).
Most pathways in SN show gene enrichment for ERK1/2, a 
key extracellular-signal-regulated protein kinase. The abnormal 
hyper-phosphorylation of tau, a gene that encodes the micro-
tubule-associated protein tau, promotes microtubule stability 
and functions as a linker protein between axonal microtubules 
and neural plasma membrane components. Its mutation in 
Alzheimer’s disease (AD) has been shown to involve the ERK 
of the mitogen-activated protein (MAP) kinase family. Both the 
intracellular and regional distribution of the active forms of both 
MEK1/2 and ERK1/2, and the accumulation of p-MEK1/2 and 
p-ERK1/2 are known, the latter found in cases with stages I–III 
neurofibrillary degeneration (36).
FigUre 1 | (a) Summary of top-10 pathways in SN_I1 (left) and SN_I2 (right). Percentage inside the pies represents enriched genes. FDR-corrected enrichment 
values are reported with listed pathway terms. (B) Summary of top-10 pathways in SN_I3 (left) and SN_I4 (right). Percentage inside the pies represents enriched 
genes. FDR-corrected enrichment values are reported with listed pathway terms.
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FigUre 2 |  (a) Summary of top-10 pathways in DRG_I1 (left) and DRG_I2 (right). Percentage inside the pies represents enriched genes. FDR-corrected enrichment 
values are reported with listed pathway terms. (B) Summary of top-10 pathways in DRG_I3 (left) and DRG_I4 (right). Percentage inside the pies represents enriched 
genes. FDR-corrected enrichment values are reported with listed pathway terms.
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TaBle 2 | lincrnas and gene targets in sn and Drg (ensembl rel 77).
lincrna left right
context-rich Target −1 MB exact location 1 MB 2 MB 3 MB
SN RGD1562521 Rgs22a 274577   •
SN Rn50_X_0667.2 Rgs18a •   217956
SN Gm26825 Stim2a •    487168
annotated evidences
SN Fam9b Vps13b •   274577
SN Rn50_X_0711.1 Creb1 116889 •
SN Ct55 Edem3 •  84281
SN Rn50_14_0846.1 Suco 242915   •
SN Rn50_13_0828.1 Zfyve28 • 18891
SN Fam178b Ptchd1 253992   •
SN Rn50_13_0839.5 Pof1b 145307  •
SN Rn50_7_1163.2 Gpd1 699513     •
SN Ino80dos Rb1cc1 609632     •
SN RP23-61N4.3 Gng11 602367     •
SN Gm26673 Thsd7a 862550      •
SN Gm26827 Peg3 413420    •
SN Gm20204 Arhgef7 493494    •
SN Gm28933 Rdh14 28368  •
SN Gm26723 Rdh14 130201   •
SN Gm26819 Klf6 1620120            •
SN Yam1 Tfb1m 965615       •
SN Gm26823 Cul2 303188  •
SN Gm4221 Zeb1 416081   •
SN 4731419I09Rik Hey1 771424      •
SN A530017D24Rik Ccm2 139918  •
SN 1700086L19Rik Klhl29 2852122                     •
SN C130071C03Rik Wdr37 85451  •
DRG 1700020I14Rik Itga8 354118   •
DRG Rn50_X_0744.2 Edem3 •  39848
DRG Rn50_13_0853.1 Chm 974768       •
DRG Rn50_7_1164.1 Lhfpl1 •    678582
DEG’s locations were within ±3 Mbps of the lincRNAs locus (preference assigned to the closest neighbors).
aDEG targets potentially relevant in terms of functional aspects, namely RGS22, RGS18 (regulators of G-protein signaling), and STIM2 (stromal interaction molecule 2). Context-rich 
evidences are richer in functional information compared to only annotated evidences. The annotations reported here are cross-referenced in Table S9 in Supplementary Material 
(comparatively between species, Ensembl releases, and Ensembl vs. NCBI).
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contextual analysis of lincrnas and 
Detection of the neighboring Degs
We detected the differentially expressed ncRNAs across DRG and 
SN. Further classification was operated into three lncRNA cat-
egories, namely pseudogenes, lincRNAs, and asRNAs. LincRNA 
sequences categorized into different types on the basis of their 
genomic location with respect to protein-coding genes have been 
explored in very few studies (9, 22). The lincRNAs, detected by 
using both mouse and rat references, were manually curated to 
verify whether they could reveal potential candidate therapeutic 
targets for NP. In particular, potential association with the 
neighboring DEG targets was selectively investigated, i.e., within 
±3 Mbps.
Table 2 shows the list of DEGs with respect to lincRNAs in 
both tissues and the corresponding annotations. The directional 
location of putative targets with respect to the genomic location 
of the lincRNAs is also reported. Analysis of lincRNAs and their 
neighboring DEGs revealed about 26 potential protein-coding 
targets in SN and 4 in DRG. In particular, we enabled a search 
for context-related information for each candidate bioentity, 
and after further manual curation of these 30 targets, we found 
examples, such as RGS22, RGS18 (regulators of G-protein sign-
aling), and STIM2 (stromal interaction molecule 2), among the 
candidate DEGs in SN (indicated by *), with the potential to be 
targets of lincRNAs.
In particular, STIM2 plays an important role in ischemia-
induced neuronal damage, and its absence in knockout mice was 
shown to interrupt blood flow in the brain, thus decreasing the 
neuronal damage caused by ischemia (2). The neuroprotective 
influence of STIM2-deficiency following an ischemic incidence 
suggests that the inhibitors of the STIM2 function might 
have potential therapeutic effect as neuroprotective agents to 
treat ischemic injury and other neurodegenerative disorders 
showing altered Ca2+ homeostasis. This basically suggests the 
role of STIM2 in hippocampus-dependent spatial memory, 
synaptic transmission, and plasticity. Since NP is likely a result 
of long-term plastic changes along somatosensory pathways, we 
hypothesize that STIM2 might play a role in NP-related synaptic 
transmission.
In addition to STIM2, we also detected a few genes from the 
family of RGS (regulators of G-protein signaling), namely, RGS18 
and RGS22, as putative targets for lincRNAs. RGS proteins share 
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a conserved domain of ~120 amino acids and are responsible for 
accelerating GTPase activity on the G-protein alpha subunit. They 
also affect physiological regulation of G-protein-mediated cell 
signaling in many tissues and organs and have been considered as 
potential drug targets in various nervous system diseases (37, 38). 
A family of RGS genes expressed in spinal cord may be involved 
in the regulation of GPCR signaling and adaptive changes of 
the nervous system, accompanying insensitivity to morphine 
observed in NP models (39). Based on the expression of RGS pro-
teins, novel targets for small molecule inhibitors might provide 
specific treatment for various pathophysiological conditions (40).
For instance, RGS18 acts as a negative regulator of the osteo-
clastogenesis (41) and also plays an essential role in the regulation 
of megakaryocyte differentiation and chemotaxis (42). Finally, 
RGS proteins accelerate the deactivation of G proteins to reduce 
the GPCS (G-protein-coupled receptors) signaling, while few 
have effector function and thus transmit signals. The range of 
functions of RGS proteins along with their dynamically regulated 
distribution in brain makes them putative targets for therapeutic 
use (43, 44). While there are no current studies that show the 
relevance of RGS18 and RGS22 to NP, other components of RGS 
proteins have been shown to contribute to NP etiology (45, 46).
annotation Pseudogenes and the Parent 
Protein coding
The contextual analysis of all the pseudogenes detected in 
both the neuronal tissues was performed. These pseudogenes 
sequences were mapped to the protein-coding genes to identify 
their associated parental genes, keeping only the top unique hits 
for downstream analysis. We further found the differentially 
expressed genes in either or both of the tissues. The detected 
pseudogenes and their corresponding parental protein-coding 
genes were listed in DRG (Table S2 in Supplementary Material) 
and in SN (Table S3 in Supplementary Material), both at the 
four different time points. These lists of entities were then used 
to draw STRING networks (Figure  3A), in an attempt to find 
the protein–protein interactions involved with pseudogene 
targets. The rat reference was used as a knowledge base, and a 
quite stringent confidence level of 0.7 was chosen to control for 
false positives. The interactions were generated by a database of 
known and predicted protein–protein interactions, following the 
STRING structure.
Figure  3B shows the protein–protein interactions for 
pseudogene targets (black boxes) obtained using mouse as the 
reference. Dotted lines indicate associations between pseudogene 
and protein-coding targets, which have been detected, but for 
which there is no interaction. In addition, we generated the pro-
tein–protein interactions for pseudogene targets obtained using 
mouse and rat references (at the same confidence level of 0.7, as 
before) for DRG (Figure S1 in Supplementary Material) and SN 
(Figure S2 in Supplementary Material). The parental protein-
coding targets were further manually curated to match possible 
transcription factors, kinases, or receptors (shown in Table S1 in 
Supplementary Material). Protein-coding targets were scrutinized 
to confirm their role in various neurodegenerative processes. 
Table 3 reports network-driven identifications of parental genes 
appearing as paths in Figures 3A,B. Heatmaps were generated for 
pseudogenes and their DEG targets (Figures 4A,B, for SN and 
DRG, respectively).
Overall, we found that the expression of pseudogenes and 
their respective targets are more prominent 14 days after injury in 
DRG, whereas in SN, they are highly expressed at 1, 4, and 7 days 
after injury. Tables S4 and S5 in Supplementary Material contain 
the list of pseudogenes and their corresponding parental protein-
coding genes in DRG and SN that are differentially expressed in 
DRG and SN at four different time points, respectively. We found 
about 12 DEGs in DRG and 134 DEGs in SN to be considered 
as potential targets for pseudogenes. In particular, we identi-
fied a number of olfactory receptors as targets of pseudogenes, 
which connect according to the network path Olr322-Olr522-
Olr490-Olr951-Olr1565-Olr1174 in the rat network and are 
mostly expressed in SN, with the exception of the path Olr322-
Olr522-Olr1565-Olr1174 expressed in DRG as well (Figure S1 in 
Supplementary Material). In general, these receptors have been 
reported to be important components for the early diagnosis of 
neurodegenerative diseases (56–63).
We then identified HSPD1 (Table 3, second row), a heat shock 
60-kDA protein1, which encodes a member of the chaperonin 
family. Studies have shown increased frequency of the pathogenic 
variant of the HSPD1 single-nucleotide variant in a subgroup of 
sudden infant death syndrome (SIDS) patients (64). Yet, another 
study showed that the mutations in HSPD1, the gene encoding 
Hsp60, are related to two human inherited diseases of the nervous 
system, spastic paraplegia and MitCHAP60 disease. The study 
shows the significance of Hsp60 chaperone in mitochondrial 
function and its relation to the formation of the respiratory chain 
complex in neuronal tissues (47). We also detected HNRNPA1 
in mouse network (Table 3, third row). This is a heterogeneous 
nuclear ribonucleoprotein A1. The levels of HNRNPA1 were 
found dysregulated in patients with AD, and the associated 
genotype is likely a risk factor for frontotemporal lobar degenera-
tion (FTLD) among the male populations (49). This network also 
includes NAP1l1, which plays a significant role in the cortical 
neuronal differentiation. NAP1 is the nucleosome assembly pro-
tein 1, which is normally used for in vitro nucleosome assembly 
reactions under physiological ionic condition (65). Other studies 
have shown that NAP1 regulates actin nucleation by forming 
a complex with WAVE regulatory protein and is selectively 
expressed in the developing cortex (66). The cytoskeletal rear-
rangements in the cortical plate play an important role in the 
cortical neuronal differentiation (51). Yet, another study reveals 
that the depletion of NAP1 could result in reduced branching of 
motor axons in the neuronal development (67). Thus, spotting 
out NAP1 is a significant finding in this study, due to its potential 
involvement in neurodegeneration.
Naturally enough, we cannot claim any direct association 
between target genes and both physiological and pathologi-
cal conditions highlighted in the studies reported in Table  3. 
Nevertheless, we stress the following two points. (a) The proteins 
assigned to network paths may or may not refer to significance 
levels under differentiated models and experimental conditions, 
but those identified here are indeed obtained from mapped 
DEGs. (b) A network context is ideal to identify hotspots (motifs, 
paths, etc.) whose relevance comes from superior robustness of 
FigUre 3 |  (a) Protein–protein interactions for pseudogene targets (black box) obtained using rat reference at confidence level 0.7. Red circle are the networks 
studied. Dotted lines indicate association between pseudogene and parental genes (the former appear superimposed, being not annotated in STRING).  
(B) Protein–protein interactions for pseudogene targets (black boxes) obtained using mouse reference at confidence level 0.7. Red circle are the networks 
studied. Dotted lines indicate association between pseudogene and parental genes (the former appear superimposed, being not annotated in STRING).
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TaBle 3 | network-driven identifications of parental genes in sn and Drg.
rat parental genes annotations: relevant gene for which 
studies are available, with reference 
model and disease
(DRG) network path: 
Pak1-Hsp90ab1-Eef1e1-Hspd1
Hspd1 (47) neurodegeneration (mouse)
Hsp90 (48) neurofibromatosis (cell lines 
and human primary schwannoma and 
meningioma cultures in vitro)
Mouse parental genes annotations and references
(SN) network path: 
Hnrnpa1-Npm1-Nap1l1
Hnrnpa1 (49) neurodegeneration (patients)
Npm1 [(50) – rev.] neurodegeneration
Nap1l1 (51) neurogenesis (mouse)
(SN) Network path: Srpr-Ube2n-
Rps27a-Rpl32-Eef2-Eef1g-Eif4g1-
Eif3c-Eif4a1-G3bp1
Ube2n (52) neuroblastoma (cell lines)
Eef2 (53) neurogenesis (Aplysia californica)
Eef1g (54) neurogenesis (in vitro model of 
TT2F mouse embryonic stem cells)
G3BP1 (55) neurodegeneration [G3bp1-
knockout (KO) mice]
Network paths are visible in Figures 3 and 4. A path between two nodes in the 
network is defined as a sequence of adjacent nodes to be traversed in order to go from 
one of the two nodes to the other.
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interactions compared to simple correlation observed at gene 
expression level, which in turn makes inference more reliable.
DiscUssiOn
In recent years, the relevance of ncRNAs has exponentially 
increased, supported in part by technological advances and in 
part by the need to overcome the current knowledge limitations 
in genomics. Two major trends have been observed. On the one 
hand, the computational community has produced an enormous 
volume of evidences with a focus on new biotype classifications 
and characterizations examined in the context of large-scale stud-
ies. Undoubtedly, ENSEMBL3 represents a main source of genome 
annotation and interpretation currently available. As prediction 
remains the most important factor determining genome annota-
tion, the way the available evidence is consolidated and curated 
differentiates ENSEMBL say, from other annotation systems [see 
an interesting reading on biotype conflicts, Zhu et al. (68)]. This 
is one of the current limitations in the analyses we have proposed 
here, as the lack of harmonization between annotations of differ-
ent DB resources makes part of the evidences disagree or con-
tradict each other. However, in many cases and especially for the 
vast majority of ncRNAs, predictive evidences may be destined to 
change, following discoveries and validations. This is in line with 
highly focused studies delivered by experimentalists with the aim 
to provide small-scale validated evidences for identifying func-
tions of ncRNAs. Notably, such research domains, computational 
and experimental, have offered almost no contact points, due to 
different scopes, approaches, and desired impacts.
We aim to contribute at establishing bridges between the two 
domains, an effort requiring to computational scientists the imple-
mentation of sophisticated tools to parse the current heterogene-
ity of evidences in support of novel or alternative interpretation 
3 http://ensemblgenomes.org/ 
especially in relation to the role of ncRNAs. Although microarray 
targeted to spinal nerve ligations have been performed for real-
time evaluation of mRNA transcripts (69, 70), no attempts have 
been made to study the expression levels of ncRNAs, and specifi-
cally for NP studies on spinal cord injury. Here, our idea was to 
develop a computational pipeline (sketched in Figure 5) to detect 
and categorize ncRNAs while annotating their putative targets. 
This way, we emphasize a methodological direction complement-
ing the search and the profiling of protein-coding genes. When 
these are analyzed with pathway annotations, only a few pathway 
terms emerged with relevance for our specific problem, while the 
majority did not convey significant evidence.
In particular, we underline the role of the neurophysiological 
process_Kappa-type opioid receptor, which is involved in the 
transmission of nerve impulses and in neurotransmitter release. 
Such limitations were bypassed by providing further important 
annotations through protein-coding genes with an assigned role 
of putative targets of lincRNAs and pseudogenes. Protein interac-
tion networks revealed then very useful to establish connectivity 
patterns between such target genes. It is important to note that 
such patterns establish dependence relationships between nodes 
through links, which reflect an underlying metric. Unlike miR-
NAs, other ncRNAs are not yet supported by sufficient knowl-
edge to allow complete annotations and systems representation 
according to networks. For this reason, we focused on building 
network configurations centered on ncRNA targets, such that 
inference can be conducted on their direct or indirect interactors.
Previously, it was shown how the differentially expressed genes 
regulated the nine classes of biological processes, but, here, we 
did an extensive repurposing of the same microarray data to do 
pathway annotations for the DEGs. As a disease model, the focus 
on NP was based on the simple premise that very little is known 
about the role of ncRNA in such process. It is known that nerve 
injury causes gene expression changes in some isolated miRNAs 
and in asRNA in the neuronal tissue. It is also known that these 
changes could be responsible for the injury-induced alterations of 
few pain-associated genes, causing neuronal excitability and pain 
hypersensitivity (22, 71). However, no knowledge is currently 
available on lncRNAs and their associated protein-coding gene 
targets. Similar knowledge gap applies also to pseudogenes and 
their associated parental genes.
We have provided evidence on novel players with a possible 
role in the regulation of NP development and maintenance, and 
whose specific functions would surely require further validation 
steps by experimentalists. As computational scientists, we inves-
tigated ncRNA expression profiles and their potential targets 
by two different approaches. First, we searched for the detected 
DE lincRNAs in coarsely defined proximal genomic regions to 
locate potential targets. We found, for instance, three examples of 
targets – RGS22, RGS18, and STIM2 – for which annotations are 
quite interesting because of the functional information available 
for them, hence the attribute context-rich assigned to these exam-
ples compared to other examples of candidates for which similar 
information is unavailable. We do not exclude, of course, that 
the mechanisms underlying lincRNA functions and their targets 
might not be centered on proximity. We only claim that evidence 
appears from targets found at proximal locations, indicating the 
FigUre 4 | continued
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need to explore further the causes of such influences. While the 
previous findings were limited to antisense, here we found targets 
for lincRNAs and pseudogenes, highlighting the fact that the 
regulation of these targets by ncRNAs needs further exploration 
in the NP domain.
Second, we analyzed DE pseudogenes and their parental 
protein-coding targets. We showed that some parental genes can 
be connected when mapped onto networks, in particular, PINs 
in our case. Interestingly, we reported various network-driven 
identifications of these aggregated parental genes linked to stud-
ies centered on various neurodegeneration and neurogenesis pro-
cesses. We also found olfactory receptors representing a densely 
connected functional module, and further literature curation 
linked them to various neurodegeneration states like Parkinson, 
Down syndrome, Huntington diseases, and Alzheimer. This, by 
no means, indicates that direct association exists with one or 
more of such diseases, also because of the variety of reference 
models reported in the studies.
As a methodological note, microarray technology is not 
comprehensive, and we may expect that by replicating our 
experimental setting with RNA-Sequence, superior evidences 
could be found to complement our current results obtained. 
Although RNA-Sequence is undoubtedly a preferable strategy 
to detect novel lncRNAs, our goal in the study was limited to 
the identification of known lncRNAs, and microarray revealed 
informative for such purpose. We expect that more and novel 
ncRNAs would emerge from using RNA-Seq. More importantly, 
we want to emphasize that we have reused the microarray data 
to identify the significant differentially expressed bioentities and 
to study their potential relevance for NP. Our results suggest 
FigUre 4 | (a) Expression levels for pseudogenes and the corresponding parental protein-coding targets that are differentially expressed in SN at four different 
time points. (B) Expression levels for pseudogenes and the corresponding parental protein-coding targets that are differentially expressed in DRG at four different 
time points.
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that novel unforeseen findings could be latent in microarray 
analyses, requiring that biologically meaningful interpretations 
from such repurposing of microarray probes may represent a 
strategy to consolidate previously acquired knowledge. Recent 
reviews stressing such points are supporting our work (72, 73).
In conclusion, given the known premises that lncRNA regula-
tion mechanisms are far from being clarified, and this includes 
the elucidation of direct/indirect and in case, intermediary 
mechanisms, it appears that targeting proteins allow to exert 
their cis or trans effects, but the factors determining, for instance, 
RNA-protein interaction are not yet well-defined.
Our study brings initial but prominent evidence of the impact 
exerted by some ncRNAs on NP. Despite the limitations of the 
approach, such as results telling about putative targets and cross-
referencing across studies on different models, an advantage of 
our methodology is that can be generalized to any model for 
which even just microarray data have been obtained. To our 
knowledge, these represent still the major fraction available to 
computational scientists, and even if the ratio with RNA-Seq-
driven studies is destined to revert, we are confident that ncRNA 
evidences can be retrieved from both experimental sources.
Finally, although most of the recent computational tools have 
tried to examine the expression and the possible regulation func-
tions of ncRNAs, it is plausible to expect that direct NP implica-
tions need future targeted studies aimed to validate the precise 
functional role of ncRNAs and their potential targets, even if the 
FigUre 5 | Methodological pipeline. The graph has been rescaled to fit the data label (452) for pseudogenes in SN. The upward red arrows pointing to 452 
indicate that rescaling has been implemented to fit all the data together. The displayed tables are included in the supplementary material.
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timeline for such milestone remains highly dependent on both 
model and type of cells under study, thus hard to predict.
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